Search research articles
Contact Us
Filters
Showing results (171-180 of 991) with videos related to
Page
of 100
Sort By:
Addiction Biology
|
December 17, 2008
Pavlovian drug discrimination with bupropion as a feature positive occasion setter: substitution by methamphetamine and nicotine, but not cocaine
Jamie L Wilkinson, Chia Li, Rick A Bevins
International Journal of Obesity (2005)
|
June 6, 2019
Disorganized attachment predicts body mass index via uncontrolled eating
Laura L Wilkinson, Angela C Rowe, Abigail Millings
European Eating Disorders Review : the Journal of the Eating Disorders Association
|
November 29, 2023
Latent classes of alcohol and cannabis use among adults with binge-spectrum eating disorders: Associations with eating disorder symptom severity and personality features
M L Wilkinson, N Karbassi, A S Juarascio
Nitric Oxide : Biology and Chemistry
|
December 5, 2022
Nitric oxide regulation of cellular metabolism: Adaptive tuning of cellular energy
Gregory Pappas, Melissa L Wilkinson, Andrew J Gow
Behavioural Pharmacology
|
May 28, 2010
Reference place conditioning procedure with cocaine: increased sensitivity for measuring associatively motivated choice behavior in rats
Carmela M Reichel, Jamie L Wilkinson, Rick A Bevins
Archives of General Psychiatry
|
June 1, 1981
Infants at risk for schizophrenia. The Jerusalem Infant Development Study
J Marcus, J Auerbach, L Wilkinson, et al.
Herz
|
April 1, 1979
Atrioventricular conduction tissues in univentricular hearts of left ventricular type
A E Becker, J L Wilkinson, R H Anderson
British Heart Journal
|
March 1, 1976
Proceedings: Tricuspid atresia--morphology and classification
R H Anderson, A E Becker, J L Wilkinson
Transfusion
|
March 1, 1974
Evaluation of commercial antiglobulin sera over a two-year period. Part I. Anti-beta 1A, anti-alpha 2D, and anti-beta 1E levels
P D Issitt, C H Issitt, S L Wilkinson
Transfusion
|
March 1, 1974
Evaluation of commercial antiglobulin sera over a two-year period. Part II. Anti-IgG and anti-IgM levels and undesirable contaminating antibodies
P D Issitt, C H Issitt, S L Wilkinson
Page
of 100
Search research articles
Search
Showing results (171-180 of 991) with videos related to
Sort By:
Page
of 100
Addiction Biology
|
December 17, 2008
Pavlovian drug discrimination with bupropion as a feature positive occasion setter: substitution by methamphetamine and nicotine, but not cocaine
Jamie L Wilkinson, Chia Li, Rick A Bevins
International Journal of Obesity (2005)
|
June 6, 2019
Disorganized attachment predicts body mass index via uncontrolled eating
Laura L Wilkinson, Angela C Rowe, Abigail Millings
European Eating Disorders Review : the Journal of the Eating Disorders Association
|
November 29, 2023
Latent classes of alcohol and cannabis use among adults with binge-spectrum eating disorders: Associations with eating disorder symptom severity and personality features
M L Wilkinson, N Karbassi, A S Juarascio
Nitric Oxide : Biology and Chemistry
|
December 5, 2022
Nitric oxide regulation of cellular metabolism: Adaptive tuning of cellular energy
Gregory Pappas, Melissa L Wilkinson, Andrew J Gow
Behavioural Pharmacology
|
May 28, 2010
Reference place conditioning procedure with cocaine: increased sensitivity for measuring associatively motivated choice behavior in rats
Carmela M Reichel, Jamie L Wilkinson, Rick A Bevins
Archives of General Psychiatry
|
June 1, 1981
Infants at risk for schizophrenia. The Jerusalem Infant Development Study
J Marcus, J Auerbach, L Wilkinson, et al.
Herz
|
April 1, 1979
Atrioventricular conduction tissues in univentricular hearts of left ventricular type
A E Becker, J L Wilkinson, R H Anderson
British Heart Journal
|
March 1, 1976
Proceedings: Tricuspid atresia--morphology and classification
R H Anderson, A E Becker, J L Wilkinson
Transfusion
|
March 1, 1974
Evaluation of commercial antiglobulin sera over a two-year period. Part I. Anti-beta 1A, anti-alpha 2D, and anti-beta 1E levels
P D Issitt, C H Issitt, S L Wilkinson
Transfusion
|
March 1, 1974
Evaluation of commercial antiglobulin sera over a two-year period. Part II. Anti-IgG and anti-IgM levels and undesirable contaminating antibodies
P D Issitt, C H Issitt, S L Wilkinson
Page
of 100